[1]王庆兰, 李敬芳, 孙小英,等. 高放射剂量对甲状腺癌脑转移患者生存期及肿瘤标志物水平的影响[J]. 实用临床医药杂志, 2017, 21:186-188. [2]姜仁伟, 王思阳, 郭栓栓, 等. 不同放射剂量对甲状腺癌术后残余癌放疗的效果观察[J]. 临床医学研究与实践, 2017, 2:23-24. [3]赵磊, 方芳, 陈琪. 免疫检查点抑制剂及联合放疗对肿瘤治疗的进展[J]. 现代免疫学, 2018, 2:170-174. [4]Srivastav S, Walitza S, Grünblatt E. Emerging role of miRNA in attention deficit hyperactivity disorder: a systematic review[J]. Adhd Deficit Hyperact Disord, 2018, 10:1-15. [5]Zhang W, Sun Z, Su L, et al. miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer[J]. Eur J Pharmacol, 2018, 825:75-84. [6]Bao C, Lu YK, Chen JS, et al. Exploring specific prognostic biomarkers in triple-negative breast cancer[J]. Cell Death Dis, 2019, 10: 807-815. [7]殷玉敬, 高辉, 郭佳, 等. 环状RNA UBAP2沉默对肺癌A549细胞体外增殖和侵袭的影响及机制[J]. 中国肺癌杂志, 2017, 20:800-807. [8]王明阳, 王光磊, 陈新亮, 等. microRNA的生物学功能及其与肿瘤诊断和治疗的研究进展[J]. 动物医学进展, 2018, 39:95-98. [9]张玉宇, 王利波, 赵钦,等. 肿瘤微环境与肿瘤细胞放射敏感性关系的研究进展[J]. 吉林大学学报(医学版), 2016, 42:1038-1044. [10]Schluckebier L, Aran V, Moraes JD. XAF1 expression levels in a non-small cell lung cancer cohort and its potential association with carcinogenesis[J]. Oncol Rep, 2017, 38:402-410. [11]Christian S, Birgit R, Markus C, et al. Sensitization of colorectal cancer cells to irinotecan by the Survivin inhibitor LLP3 depends on XAF1 proficiency in the context of mutated p53[J]. Arch Toxicol, 2018, 92:2645-2648. [12]Iravani O, Bay BH, Yip WC. Silencing HS6ST3 inhibits growth and progression of breast cancer cells through suppressing IGF1R and inducing XAF1[J]. Exp Cell Res, 2017, 350:380-389. [13]殷德涛, 陈国, 李红强,等. 甲状腺乳头状癌中XAF1基因启动子甲基化及其蛋白表达的相关性[J]. 中华医学杂志, 2012, 92:1967-1970. |